Neuropilin 2 stabilises adherens junctions and protects against endothelial activation by promoting the interaction between VE ... https://t.co/DlziSwps2I #biorxiv_cellbio
Paper from my #PhD is out! We profiled the gut and oral #microbiome of metastatic #breastcancer patients. This project was a long one in collaboration with @wearemedsir. Thanks @TheQuadram@bigctweets for supporting my studentship. It's published 🎉.
https://t.co/cYXNwRrnJz
Delighted to share that I’ll be joining the @QuadramInstitute as Director & CEO in April 2025! I am honoured to work with an incredible team and partners to push the boundaries of gut health, microbiology, and food science research.
🥳I'm incredibly honoured to receive the @MicrobioSoc Peter Wildy Prize 2025 for #scicomm, a true team prize! Huge thanks to those who nominated me & to incredible collaborators & team members. So many people to thank - I'll be highlighting them all in my prize lecture!🦠
🚨 Exciting opportunity at @unibirmingham@unibirm_CMH! 🚨 Offering a 2-year Springboard Fellowship designed to support high-calibre #PDRA researchers in developing strong proposals for fellowships like ERC Starter Grants, Future Leaders Fellowship, Wellcome/MRC CDA, and more.
🧵 Exciting new preprint! 🚨 We’ve uncovered how Bifidobacterium pseudocatenulatum capsular exopolysaccharides (EPS) can enhance systemic anti-tumour immunity in pre-clinical breast cancer models. Here's what we found 👇 #cancerresearch#microbiome
3/ Think of it as bacteria with a “sweeter” edge - the sugars in the EPS are driving immune responses that fight tumours. This unique mechanism positions Bifidobacterium EPS as a potential new class of therapeutic compounds in cancer treatment. 💥 #immunotherapy
SO pleased to see this study now published @MolMetab - led by the fantastic @JLopTello! Jorge is currently setting up his own lab @UAM_Medicina so definitely keep an 👀out for further exciting work in this area and research opportunities!